These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 23462066)
1. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? Alexander ES; Machan JT; Ng T; Breen LD; DiPetrillo TA; Dupuy DE J Vasc Interv Radiol; 2013 Apr; 24(4):476-82. PubMed ID: 23462066 [TBL] [Abstract][Full Text] [Related]
2. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer. Kwan SW; Mortell KE; Hippe DS; Brunner MC J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308 [TBL] [Abstract][Full Text] [Related]
3. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258 [TBL] [Abstract][Full Text] [Related]
6. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system. Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444 [TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496 [TBL] [Abstract][Full Text] [Related]
8. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation. Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. Shah A; Hahn SM; Stetson RL; Friedberg JS; Pechet TT; Sher DJ Cancer; 2013 Sep; 119(17):3123-32. PubMed ID: 23720093 [TBL] [Abstract][Full Text] [Related]
10. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. Ng T; Ryder BA; Chern H; Sellke FW; Machan JT; Harrington DT; Cioffi WG J Thorac Cardiovasc Surg; 2012 Apr; 143(4):815-9. PubMed ID: 22325327 [TBL] [Abstract][Full Text] [Related]
11. Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer. Ambrogi MC; Fanucchi O; Dini P; Melfi F; Davini F; Lucchi M; Massimetti G; Mussi A Eur Respir J; 2015 Apr; 45(4):1089-97. PubMed ID: 25700387 [TBL] [Abstract][Full Text] [Related]
12. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. Zemlyak A; Moore WH; Bilfinger TV J Am Coll Surg; 2010 Jul; 211(1):68-72. PubMed ID: 20610251 [TBL] [Abstract][Full Text] [Related]